Anemia Etiology Evaluation in Ethiopia (AnemEE)

President and Fellows of Harvard College

Status: Completed

Conditions: Anemia

Treatments: Other: Risk factors for anemia

Study type: Observational

Funder types: Other

Identifiers

NCT04002466

OPP1179606

Details and patient eligibility

About

The AnemEE study is a population-based anemia etiology survey in six regions of Ethiopia. The primary aim of the study is to evaluate the relative contribution of risk factors for anemia among children, women of reproductive age, and adult men. The study data are intended to inform evidence-based decision-making on anemia control interventions.

Full description

The AnemEE study is a population-based cross-sectional survey of children (6-59 months), adult women of reproductive age (15-49 years) and adult males (15-49 years) in six regions of Ethiopia (Afar, Amhara, Tigray, Oromia, Southern Nations, Nationalities and Peoples' Region and Addis Ababa). The study will enroll approximately 5,100 participants and will be conducted in two survey rounds; one survey round in the Belg season and one survey round in the Meher season. All participants will have hemoglobin assessed and will have standardized questionnaires administered to assess sociodemographic, diet, morbidity, and other health/nutrition factors. All participants will also have assessments of anthropometric measures, malaria, and soil transmitted helminth infection. A subset of participants will also have serum ferritin, CRP, AGP, vitamin B12, and folate concentrations assessed. The study data will be used to determine the relative contributions of risk factors for anemia.

Enrollment: 5,114 patients

Sex: All

Ages: 6 months to 48 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Women of reproductive age

   • Female living in a selected household that has a woman 15-49 years of age
   • Aged 15-49 years

2. Adult Men

   • Male living in a selected household that has a woman 15-49 years of age
   • Aged 15-49 years

3. Children

   • Male or female child living in a selected household that has a woman 15-49 years of age
   • Aged 6-59 months

Exclusion criteria

• Does not provide informed consent

Trial design

5,114 participants in 3 patient groups

Children (6-59 months)

Treatment:

Other: Risk factors for anemia

Women of Reproductive Age (15-49 years)

Treatment:

Other: Risk factors for anemia

Adult Men (15-49 years)

Treatment:

Other: Risk factors for anemia